palliative-clinical-trials-2019-scientifictracks

10 / 23

Page 32
Notes:
allied
academies
February 28-March 01, 2019 | Paris, France
Palliative Care, Obstetrics and Gynecology Stroke and Clinical Trials
International Conference on
Joint Event on
International Conference on
&
Journal of Research and Reports in Gynecology and Obstetrics | Volume: 3
Perineal chronic pain and dyspareunia after childbirth
Beatriz M Moya Esteban and Juan Antonio Solano Calvo
Hospital Universitario Príncipe de Asturias, Spain
Until recently, a little attention was given to perineal
consequences after delivery. Perineal pain can impact
woman’s daily activities. Dyspareunia is also common in
the postnatal period. Both complications can be potentially
devastating for mothers affecting relationships with their
partner and bonding with the new born child.
It has been reported that 42% of women with a vaginal
delivery will continue with these symptoms within the first
2 week postpartum. Up to 92% of mothers will complain of
perineal pain on the day after delivery. Most of them will
experience a gradual recovery within a 2-month period.
However, chronic lower genital tract pain has been observed
in a significant number of women 1 year after delivery. If
we focus on the incidence of dyspareunia, the number of
affected women increases notably. A 60% of these mothers
will report coital difficulties after 3 months and 30% will
continue with these issues 6 months after delivery. Our own
statistics show a prevalence of perineal pain of 28% and 10%
at 3 month and 6 months postpartum, respectively. Thus,
dyspareunia continues in 38% of cases at 3 months and 13%
at 6 months. These values have been determined using the
validated pain scores (visual analogue scales for pain: VAS) in
our pelvic for unit. We examine women who had given birth
in our hospital 2 and 6 months after delivery dyspareunia.
After the medical interview, all patients are examined to
look for trigger points. We consider a trigger point to be
those where the vaginal/perineal examination set of the
maximum degree of pain. We propose a treatment based
on intravaginal injection directly into the trigger points. All
of them reveal a complete relief of their symptoms 2 weeks
after the administration of the medication.
Speaker Biography
Beatriz M Moya Esteban is a specialist in Obstetrics and Gynecology at Hospital
Universitario Príncipe de Asturias in Alcalá de Henares. She has published in medical
journalswithinSpainandEurope.ShehasalsogivenseverallecturesinSpaindealingwith
varioustopicswithinherspecialty.Sheiscurrentlypartoftheteamthatconductsaclinical
trial about perineal pain and dyspareunia treatment within the postpartum period.
e:
Beatriz M Moya Esteban et al., Res Rep Gynaecol Obstet, Volume 3
DOI: 10.4066/2591-7366-C1-002